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OBJECTIVEdInsulin resistance (IR) is associated with diabetes. IR is higher during puberty in
both sexes, with some studies showing the increase to be independent of changes in adiposity.
Few longitudinal studies have reported on children, and it remains unclear when the rise in IR
that is often attributed to puberty really begins. We sought to establish from longitudinal data its
relationship to pubertal onset, and interactions with age, sex, adiposity, and IGF-1.
RESEARCHDESIGNANDMETHODSdThe EarlyBird Diabetes study is a longitudinal
prospective cohort study of healthy children aged 5–14 years. Homeostasis model assessment
(HOMA-IR), skinfolds (SSF), adiposity (percent fat, measured by dual-energy X-ray absorpti-
ometry), serum leptin, and IGF-1 were measured annually in 235 children (134 boys). Pubertal
onset was adduced from Tanner stage (TS) and from the age at which luteinizing hormone (LH)
ﬁrst became serially detectable ($0.2 international units /L).
RESULTSdIR rose progressively from age 7 years, 3–4 years before TS2 was reached or LH
became detectable. Rising adiposity and IGF-1 together explained 34% of the variance in IR in
boys and 35% in girls (both P , 0.001) over the 3 years preceding pubertal onset. The contri-
bution of IGF-1 to IR was greater in boys, despite their comparatively lower IGF-1 levels.
CONCLUSIONSdIR starts to rise in mid-childhood, some years before puberty. Its emer-
gence relatesmore to the age of the child than to pubertal onset. More than 60% of the variation in
IR prior to puberty was unexplained. The demography of childhood diabetes is changing, and
prepubertal IR may be important.
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Amiel et al. (1) were the ﬁrst to reportthat insulin resistance (IR) is higherin puberty. Glucose clearance was
;30% lower in children between Tanner
stage (TS) 2 and TS4 compared with pre-
pubertal children or adults. Greater fat
mass (2), sex steroids (3), and higher con-
centrations of growth hormone/IGF-1
(4,5) have variously been proposed to ex-
plain the difference.
Several groups have replicated Amiel’s
observation, most reporting that IR was
higher in TS2–4 than TS1 (prepuberty),
and lower again by TS5 (2,4,6,7). How-
ever, of the studies making measurements
at different stages of puberty (8–14), only
two did so on more than two occasions in
the same cohort (12,13), and then with
contradictory ﬁndings. Hoffman et al.
(12) found no changes in IR between
TSs, once adjusted for BMI, whereas
Moran et al. (13) reported a signiﬁcant
ﬂux during adolescence, independent of
changes in body composition. Interpreta-
tion is all themore difﬁcult because existing
longitudinal studies of IR during puberty
report on groups of children of widely vary-
ing age at baseline (8–14). The youngest
reported mean age was 9.2 6 1.3 years
in a repeated measures study by Goran
and Gower (9). Other such studies began
with children aged 9.8–13 years (8,10–13)
whereas Travers et al. (14) reported only
from TS2. A cohort of uniform age with
measures from early childhood, in addition
to measures of pubertal maturation, is
needed to establish when IR begins to rise
in relation to puberty.
The method used to detect pubertal
onset is important for a study of pubertal
IR, but the issue is not straightforward.
Tanner staging classiﬁes puberty accord-
ing to anatomical responses that occur
months downstream of hypothalamic ac-
tivation, whereas the metabolic changes of
puberty may respond to the same cues
independently, and with a different tempo.
Pubertal maturation of the hypothalamo-
pituitary-gonadal axis reportedly begins
with a rise in luteinizing hormone (LH)
around 8–9 years in girls, and 1–2 years
later in boys (15), although longitudinal
data are few. Frisch and McArthur (16)
ﬁrst suggested that a critical proportion
of body fat may be required for the initia-
tion of the hypothalamo-pituitary-gonadal
pubertal process, and, more recently, the
adipokine leptin has been implicated as
the signal responsible (17).
EarlyBird is a prospective cohort
study of healthy children extending over
the course of childhood, and the aims of
this analysis were to establish, from lon-
gitudinal data, the trends in IR during
contemporary childhood and their rela-
tionship to age, TS, LH, IGF-1, and adi-
posity. We were particularly concerned to
establish at what age, or pubertal stage, the
rise in IR started, and to what it might be
attributed.
RESEARCH DESIGN AND
METHODS
Participants
EarlyBird is a prospective, noninterven-
tion cohort study that recruited 307
healthy children (170 boys) at 5 years
from randomly selected schools, based in
the city of Plymouth, U.K. The majority
(98%) are Caucasian, with a wide socio-
economic mix representative of the U.K.
as a whole (mean index of multiple
deprivation score 21.7, range 6.5–73.0;
U.K. mean 26.3). The protocol has been
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described in detail elsewhere (18). The
main research question is, which children
develop IR, and why? The cohort is of
uniform age (mean age at recruitment
4.9 years, SD 0.3), children were re-
viewed at 12 monthly intervals (61
month) and results are reported here
from 5 to 14 years. Written consent of
the parent, and assent from the child at
each visit, was obtained. Ethical approval
was granted in 1999. The study was con-
ducted according to the principles ex-
pressed in the Declaration of Helsinki.
Measures
Adiposity was measured in two ways.
Skinfolds (SSF) (skinfold calipers; Holtain
Ltd., Crosswell, Crymych, Dyfed, U.K.)
were measured annually in duplicate
by one of two trained nurses over the
biceps and triceps of the left arm and sub-
scapular, suprailiac, and para-umbilical
areas, and the mean was calculated for
each measure. Body fat (percent fat) was
measured annually from 7 years by dual-
energy X-ray absorptiometry (Lunar Prod-
igy Advanced fan beam system; Lunar
Corporation, Madison, WI). All blood
samples were taken fasting between
0900 and 0945 h and included serum
insulin (DPC Immulite, Los Angeles, CA;
cross-reactivity with proinsulin ,1%),
glucose, and LH. Glucose and LH were
analyzed within 3 h of collection. Insulin
was analyzed weekly in batches on serum
frozen at2808C. The interassay coefﬁcient
of variation for LH was,5.0%, and for in-
sulin 8.0% at 2.87 mU/L. The correspond-
ing limits of detection were,0.01 and 2.0
mU/L, respectively. Leptin and IGF-1 were
measured in batches on serum stored at
2858C for 6–18 months by Naveed Sattar
(University of Glasgow, Glasgow, U.K.),
using an in-house radioimmunoassay vali-
dated against the commercially available
Linco assay. The interassay coefﬁcient of
variation for leptin was ,10% over the
sample concentration range and the detec-
tion limit 0.5 ng/mL. The corresponding
values for IGF-1 were,10% and 2 mg/L.
IR was derived from homeostasis
model assessment (HOMA2-IR) (19).
HOMA has been validated in children
against the hyperinsulinemic clamp with
correlations of r . 0.9 (20).
Pubertal measures
The EarlyBird study is concerned with
metabolic more than anatomical change
and, in an attempt to incorporate a more
inclusive concept of puberty, its onset was
deﬁned in two ways:
1. TS self-assessment. From 9 years, each
child (and their parent in the early
years) was shown line drawings rep-
resenting genital development for boys,
breast development for girls, and pubic
hair development for both, and asked
to choose the picture for each thatmost
closely matched their own develop-
ment. The drawings have been vali-
dated (21) and agree, to within one TS,
by 76% with clinical assessment of
genital development (k = 0.48) and
88% with pubic hair development (k =
0.68). A mean score for both Tanner
measures (genital/breast and pubic
hair development) was calculated at
each age. A mean score of 1.5 (e.g.,
genital stage 2, pubic hair stage 1) was
treated as TS2, likewise a score of 2.5
was treated as TS3, etc. TS1 represents
prepuberty (no phenotypic change),
TS2 early puberty (ﬁrst phenotypic
change), TS3 mid-puberty, TS4 late
puberty, and TS5 the end of puberty
(adult phenotype).
2. LH. The age at which LH ﬁrst became
detectable at $0.2 units/L (and re-
mained so subsequently) was desig-
nated LH0.The years before LHbecame
detectable were correspondingly desig-
nated21,22, etc., up to26; and those
Table 1dCohort characteristics ages 5–14 years
Age
TS1
n (%)
TS2
n (%)
TS3+
n (%)
LH
units/L BMIsds % Fat
SSF
(cm)
IR
(HOMA)
IGF-1
(mg/L)
Leptin
(ng/mL)
Boys (n = 134)
5 years d d 0.01 (0.01) 0.19 (0.18) d 3.63 (0.22) 0.48 (0.08) 64.72 (5.12) 2.51 (0.44)
6 years d d 0.01 (0.01) 0.17 (0.18) d 3.80 (0.24) 0.36 (0.06) 82.27 (6.36) 2.53 (0.44)
7 years d d 0.01 (0.00) 0.21 (0.18) 2.60 (1.20) 4.17 (0.28) 0.33 (0.04) 97.51 (6.36) 2.75 (0.62)
8 years d d 0.01 (0.00) 0.28 (0.20) 2.66 (1.72) 4.57 (0.36) 0.37 (0.06) 106.70 (6.08) 3.19 (1.18)
9 years 107 (80) 26 (19) 1 (1) 0.03 (0.01) 0.38 (0.18) 2.78 (1.56) 5.01 (0.40) 0.52 (0.06) 138.38 (8.38) 4.53 (1.06)
10 years 104 (77) 28 (21) 2 (2) 0.15 (0.02) 0.43 (0.20) 2.90 (1.66) 5.25 (0.46) 0.76 (0.08) 137.00 (8.62) 5.31 (1.38)
11 years 91 (68) 38 (28) 5 (4) 0.58 (0.05) 0.34 (0.20) 2.96 (1.74) 5.50 (0.48) 0.69 (0.08) 131.62 (7.98) 4.06 (1.16)
12 years 19 (14) 83 (62) 32 (24) 1.14 (0.08) 0.42 (0.20) 3.03 (1.70) 5.62 (0.52) 0.83 (0.08) 151.41 (11.12) 4.76 (1.24)
13 years 9 (7) 46 (34) 79 (59) 1.84 (0.10) 0.46 (0.22) 2.97 (1.78) 5.37 (0.50) 0.86 (0.10) d d
14 years 0 24 (18) 110 (82) 2.50 (0.10) 0.34 (0.20) 2.90 (1.70) 5.48 (0.46) 0.90 (0.12) d d
Girls (n = 101)
5 years d d 0.01 (0.00) 0.52 (0.20) d 4.57 (0.17) 0.64 (0.08) 79.84 (6.60) 3.60 (0.80)
6 years d d 0.01 (0.00) 0.50 (0.20) d 4.90 (0.21) 0.51 (0.08) 98.49 (7.28) 3.63 (1.12)
7 years d d 0.01 (0.00) 0.54 (0.22) 3.00 (1.72) 5.37 (0.48) 0.43 (0.06) 114.43 (8.26) 4.62 (1.32)
8 years d d 0.01 (0.00) 0.53 (0.22) 3.09 (2.10) 5.89 (0.50) 0.45 (0.08) 125.21 (9.02) 5.31 (1.68)
9 years 91 (90) 10 (10) 0 0.05 (0.04) 0.61 (0.22) 3.23 (1.88) 6.46 (0.58) 0.74 (0.10) 167.34 (12.50) 7.24 (1.86)
10 years 85 (84) 15 (15) 1 (1) 0.21 (0.06) 0.62 (0.24) 3.30 (1.80) 7.08 (0.60) 0.91 (0.12) 181.27 (15.84) 8.76 (2.16)
11 years 74 (74) 25 (24) 2 (2) 0.99 (0.15) 0.57 (0.24) 3.35 (1.86) 7.24 (0.60) 1.02 (0.14) 194.42 (17.72) 8.00 (1.94)
12 years 27 (27) 52 (51) 22 (22) 2.81 (0.39) 0.67 (0.24) 3.35 (1.86) 7.41 (0.62) 1.38 (0.20) 270.43 (21.46) 9.78 (1.90)
13 years 5 (5) 29 (29) 67 (66) 4.50 (0.34) 0.77 (0.26) 3.37 (1.82) 7.24 (0.68) 1.31 (0.16) d d
14 years 0 19 (19) 82 (81) 5.96 (0.52) 0.84 (0.24) 3.47 (1.90) 8.13 (0.60) 1.20 (0.16) d d
Data are means (SE) and n (%). BMIsds, BMI SD score.
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after it became detectable were desig-
nated +1, +2, and +3. The use of a single
LH measure to diagnose puberty has
been described by Houk et al. (22).
Statistical analyses
Analyses were performed using SPSS
version 16. Children were included in
the analyses if they had HOMA-IR mea-
sures on at least 5 out of the 10 possible
time points, including the 14-year mea-
sure (n = 134 boys, 101 girls). Those ex-
cluded did not differ by way of SSF, BMI
SD score (BMIsds), orHOMA-IR at baseline
(5 years) compared with those included (all
P. 0.21). SSF, dual-energy X-ray absorp-
tiometry percent fat, HOMA-IR, IGF-1, and
leptin had positively skewed distributions
and were log transformed for analysis.
A difference of 0.1 in the mean of
HOMA-IR was deemed signiﬁcant in both
sexes (.80% power). With 134 boys and
101 girls, correlation coefﬁcients above
r = 0.24 (boys) and r = 0.28 (girls) would
be signiﬁcantly different from zero with
80% power, P , 0.05. Paired Student
t tests compared means at different ages,
and correlations were established by Pear-
son correlation. Linear mixed effects
models provide a powerful and ﬂexible
tool for modeling longitudinal data, per-
mitting the inclusion of repeated mea-
sures, co-correlated data, data missing at
random, and inclusion of unlimited fac-
tors and covariates. Diagnostic plots of
the ﬁnal models showed no apparent vio-
lations of the assumptions of residual nor-
mality or homoscedasticity.
RESULTS
Cohort characteristics
The cohort characteristics from 5 to 14
years are shown in Table 1. The variance
in age at each time point was small (SD,
60.3 years), and BMI was standardized to
exact age. All measures of fatness rose
progressively in both sexes. Serum leptin
(a marker of adiposity released exclu-
sively by adipocytes) and IGF-1 (the hor-
mone largely responsible for linear
growth) again both rose progressively
throughout.
Onset of puberty
TS. At 9 years, 19% of boys and 10% of
girls self-reported TS2, and all reported
TS2 by 14 years (Table 1). Boys reported
TS2 (genital development) at 9.95 years,
and TS2 (pubic hair development) at
11.07 years; girls at 10.66 years and
11.16 years, respectively.
Biochemical (LH). LH was undetectable
in 99.8% of children from 5 to 8 years.
Isolated LH values of 0.4–0.7 units/L, re-
spectively, were detected in three individ-
uals at 5, 6, and 8 years; all of which
returned to ,0.2 the subsequent year.
The cumulative proportion of children
with detectable LH at each age is shown
in Fig. 1A. Although LH began to rise
around the same age (9–10 years) in
both sexes, its serum concentration rose
more quickly in the girls (Fig. 1B). By 14
years, only two boys still had undetect-
able LH levels.
Trends in HOMA-IR
Girls had higher IR than boys at each age
(P, 0.05). Adjusting for adiposity atten-
uated this sex difference, but girls re-
mained signiﬁcantly more insulin resistant
at 5, 6, 13, and 14 years (P , 0.05).
HOMA-IR fell from 5 to 7 years in both
sexes, but rose thereafter, almost linearly,
to 14 years (Fig. 2A). The trends in IR
plotted during the 6 years that preceded
pubertal onset (TS2) (Fig. 2B) and LH on-
set (Fig. 2C) illustrate clearly how IR in
childhood begins to rise asmany as 4 years
in advance of any phenotypic or pituitary
evidence of puberty in both boys and girls.
A similar pattern was seen when IR was
plotted in relation to onset of pubic hair
(PH) development (Supplementary Fig. 1),
with signiﬁcant increases in IR beginning
4 years before TS2.
Models
As expected, leptin correlated strongly
with SSF and percent fat (r = 0.6–0.8 in
both sexes), and moderately with IR in-
dependently of percent fat (partial corre-
lation IR and leptin; r = 0.23 [boys] and
0.32 [girls], both P, 0.001). In a regres-
sion analysis, change in leptin over the
Figure 1dLH from 5 to 14 years (y).A: Cumulative proportion of childrenwith LH$0.2 units/L.
B: LH mean (2 SE).
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3 years preceding onset of puberty (LH)
was not associated with age at onset of
puberty in the boys (P = 0.8), and was
only weakly (inversely) associated in the
girls (b = 20.10, P = 0.02). Girls with a
greater increase in leptin entered puberty
earlier.
The varying contributions of fat, IGF-1,
and age to IR over the ﬁnal four pre-
pubertal years are shown in Table 2. Fat
alone explained 25% of the variance in
IR in boys (30% in girls), whereas IGF-1
contributed 17% in boys but only 6% in
girls. Model 6 shows the combined effect
of all three variables. Each 1% increase in
fat was associated with a 2.79% (3.67%)
increase in IR in boys (girls), each 1 mg/L
increase in IGF-1 was associated with a
0.29% (0.21%) increase in IR, and each
additional year of age was associated with
19.24% (11.29%) increases in IR.
When SSF was substituted for per-
cent fat, the results were very similar (not
shown). BMIsds alone explained 12% of
the variance in IR in boys and 20% in girls
(not shown).The models were repeated
using data over the 4 years immediately
preceding the rise in LH (LH24,23,22,
and 21) (Supplementary Table A1). The
contributions of age, fatness, and IGF-1
were almost identical to those in Table 2
(percent fat explained 27% of the variance
of IR in boys and 31% in girls; IGF-1 ex-
plained 11 and 12%, respectively; and the
combination of percent fat, IGF-1, and
age explained 43 and 39%, respectively).
CONCLUSIONSdThe IR of early ad-
olescence is usually attributed to puberty,
but our data suggest that it emerges well
before the rise in LH that initiates puberty
and before any discernible physical
changes. The prepubertal increase in IR
was partially accounted for by increases
in adiposity, with percent fat alone ex-
plaining 25 and 30% of the variation in
IR in boys and girls, respectively. Type 2
diabetes is increasingly common in child-
hood, and the majority of diabetic chil-
dren are female (23), consistent with their
greater adiposity and IR. However, even
when accounting for increases in percent
fat, IGF-1, and age, over half of the total
variance in IR remained unexplained
(model 6).
We are unsure why insulin demand
should begin to rise from as early as 7
years, although three observations are
noteworthy. First, adiposity starts to rise
around the same age, and fat is known
to reduce insulin action. Second, serum
IGF-1 rises progressively as puberty
Figure 2dHOMA-IR (mean 6 2 SE) according to chronological age (A), pubertal stage by LH
(B), and pubertal stage by TS (C). *P , 0.05; **P , 0.01; ***P , 0.001, value signiﬁcantly
different from preceding year (paired Student t test). y, year.
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approaches, and the growth hormone/IGF
axis is known to be associated with IR
(24). In the current study, IGF-1 contrib-
uted an additional 3% to the variance of IR
in both sexes, after accounting for the ef-
fects of adiposity and age. The higher IGF-
1 levels in girls may relate to their greater
adiposity, or may reﬂect the fact that low
levels of estrogen produced prepubertally
in girls could have a sensitizing effect on
growth hormone, thereby increasing both
IGF-1 and IR. Alternatively, since both in-
sulin and IGF-1 belong to the same pro-
insulin superfamily, girls could be more
“IGF-1 resistant” in the same way that they
are more insulin resistant.
Third, adrenarche occurs around 6–8
years. Adrenarche precedes activation of
the gonadal axis and is characterized by
an abrupt rise in the adrenal androgen
dehydroepiandrosterone (25). Although
speculative, it is possible that dehydro-
epiandrosterone (sulfate) is responsible
for the age-dependent rise in IR either di-
rectly or indirectly by promoting fat accu-
mulation. Adrenarche has been linked
before to IR in girls (3), though not in
boys (26).
To our knowledge, this is the ﬁrst
study of puberty to track the behavior of
LH alongside traditional Tanner staging.
Hormonal changes inevitably precede the
phenotypic changes for which they are
responsible, and the sex differences in
timing of Tanner staging are universally
taken to mean that hormonal activation
begins earlier in girls than in boys (15).
Our present observations, on the other
hand, suggest that puberty is signaled by
LH at the same age in boys as in girls, and
that it is more likely a difference in the
tempo of subsequent change, than the
timing of ﬁrst release, that distinguishes
the sexes. Whatever, IR rises well before
any discernible puberty, endocrine or
anatomical.
This study has strengths and weak-
nesses. The ﬁndings we report depended
on a truly longitudinal design, annual fa-
sting blood samples, and a cohort of uni-
form age to best resolve age-related
changes. Together, they provided the op-
portunity for using multilevel modeling to
detect and evaluate interactions over time
(change for change analysis), a technique
that is substantially more robust than
simple cross-sectional association or re-
gression. The study is nevertheless rela-
tively small and the phenotypic changes of
pubertal onset were, for ethical reasons,
self-reported rather than clinician as-
sessed. We did not record Tanner staging
before the age of 9 years, but subjective
overestimation almost certainly accounts
for the apparently large numbers of boys
entering puberty at the age of 9 years. This
places constraints on the use of self-report
and makes the measurement of LH an
attractive (and objective) alternative
marker for the timing of pubertal onset.
The boys’ estimation of pubic hair devel-
opment appeared more plausible, how-
ever, and when IR was plotted in relation
to PH rather than in conjunctionwith gen-
ital development, the rise in IR began 4
years before TS2 in both sexes. The use
of LH as a marker of pubertal onset is
novel and has yet to be widely accepted.
Both LH and follicle-stimulating hormone
are involved in the initiation of estrogen
and testosterone production, although we
report here only the behavior of LH. Fi-
nally, the observations can apply with any
certainty only to children of Caucasian or-
igin. Data collection in the EarlyBird study
is still in progress andwill continue to ﬁnal
height (adulthood).
In summary, IR is already rising from
7 years of age in contemporary boys and
girls, ;3–4 years before pubertal onset,
however it is deﬁned. The rise can partly
be explained by the accumulation of fat,
and to a lesser extent by rising IGF-1.
There remains an age-related, but unex-
plained, residual that might be ascribed to
the rise in adrenal hormones. The demog-
raphy of childhood diabetes is changing,
and prepubertal IR may be important.
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Table 2dContributions to prepubertal IR
Explanatory variables
Parameter estimate
(95% CI), % fat
Parameter estimate
(95% CI), IGF-1
Parameter estimate
(95% CI), age R2 for model P for model
Boys
Model 1: % fat 4.18 (3.45–5.01) 0.25 ,0.001
Model 2: IGF-1 0.70 (0.50–0.82) 0.17 ,0.001
Model 3: age 30.47 (25.08–36.12) 0.26 ,0.001
Model 4: % fat + IGF-1 3.51 (2.74–4.26) 0.48 (0.33–0.66) 0.34 ,0.001
Model 5: % fat + age 3.04 (2.29–3.77) 22.75 (17.70–28.15) 0.42 ,0.001
Model 6: % fat + IGF-1 + age 2.79 (2.12–3.46) 0.29 (0.16–0.42) 19.24 (14.22–24.36) 0.45 ,0.001
Girls
Model 1: % fat 4.50 (3.71–5.29) 0.30 ,0.001
Model 2: IGF-1 0.40 (0.29–0.58) 0.06 ,0.001
Model 3: age 22.75 (17.06–28.62) 0.19 ,0.001
Model 4: % fat + IGF-1 3.97 (3.24–4.81) 0.28 (0.15–0.40) 0.35 ,0.001
Model 5: % fat + age 3.87 (3.25–4.50) 13.54 (8.98–18.29) 0.36 ,0.001
Model 6: % fat + IGF-1 + age 3.67 (3.05–4.39) 0.21 (0.10–0.33) 11.29 (6.61–16.18) 0.39 ,0.001
Linear mixed-effects models; dependent variable log IR over last 4 years preceding TS2 (at TS24,23,22, and21). Percent fat and IGF-1 were added as ﬁxed effects,
and age was added as both a ﬁxed and a random effect. Parameter estimates and 95% CIs are back transformed and represent the percent increase in IR for each 1 unit
increase in the explanatory variable. Contribution of all individual estimates was signiﬁcant at P , 0.001.
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